+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antifungal Drug"

From
From
Onychomycosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Onychomycosis - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 87 Pages
  • Global
From
FOSMANOGEPIX - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

FOSMANOGEPIX - Emerging Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
REZAFUNGIN - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

REZAFUNGIN - Emerging Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
From
From
Onychomycosis Market Report and Forecast 2024-2032 - Product Thumbnail Image

Onychomycosis Market Report and Forecast 2024-2032

  • Report
  • October 2023
  • 160 Pages
  • Global
From
Anti-Infective Market Report and Forecast 2023-2031 - Product Thumbnail Image

Anti-Infective Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
Loading Indicator

The Antifungal Drug market is a subset of the larger Infectious Diseases Drugs market. Antifungal drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common antifungal drugs include azoles, polyenes, and echinocandins. Azoles are the most commonly prescribed antifungal drugs, and are used to treat a wide range of fungal infections. Polyenes are used to treat more serious fungal infections, while echinocandins are used to treat severe fungal infections. The Antifungal Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Other companies in the market include Bayer, Sanofi, Allergan, and Johnson & Johnson. Show Less Read more